Pediatric Pulmonology 2022 year in review: Rare and diffuse lung disease
- PMID: 37493100
- DOI: 10.1002/ppul.26603
Pediatric Pulmonology 2022 year in review: Rare and diffuse lung disease
Abstract
The field of rare and diffuse pediatric lung disease continues to evolve and expand rapidly as clinicians and researchers make advancements in the diagnosis and treatment of children's interstitial and diffuse lung disease, non-cystic fibrosis bronchiectasis, and primary ciliary dyskinesia. Papers published on these topics in Pediatric Pulmonology and other journals in 2022 describe newly recognized disorders, elucidate disease mechanisms and courses, explore potential biomarkers, and assess novel treatments. In this review, we will discuss these important advancements and place them in the context of existing literature.
Keywords: bronchiectasis; congenital abnormalities; interstitial lung disease; primary ciliary dyskinesia.
© 2023 Wiley Periodicals LLC.
References
REFERENCES
-
- Bradford L, Ross MK, Minso J, et al. Interstitial lung disease in children with rubinstein-taybi syndrome. Pediatr Pulmonol. 2022;57(1):264-272.
-
- Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M. Abca3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med. 2004;350(13):1296-1303.
-
- Wambach JA, Casey AM, Fishman MP, et al. Genotype-phenotype correlations for infants and children with abca3 deficiency. Am J Respir Crit Care Med. 2014;189(12):1538-1543.
-
- Xu KK, Wegner DJ, Geurts LC, et al. Biologic characterization of abca3 variants in lung tissue from infants and children with abca3 deficiency. Pediatr Pulmonol. 2022;57(5):1325-1330.
-
- Liptzin DR, Pickett K, Brinton JT, et al. Neuroendocrine cell hyperplasia of infancy. clinical score and comorbidities. Ann Am Thorac Soc. 2020;17(6):724-728.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
